Profit: Research Therapy methods for the application of therapeutic vaccines HPV-AmpliVak in HPV+ head-neck tumors (Q3300940): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item: import item from Germany) |
||||||
| Property / EU contribution | |||||||
327,791.28 Euro
| |||||||
| Property / EU contribution: 327,791.28 Euro / rank | |||||||
Normal rank | |||||||
| Property / co-financing rate | |||||||
80.0 percent
| |||||||
| Property / co-financing rate: 80.0 percent / rank | |||||||
Normal rank | |||||||
Revision as of 11:57, 27 October 2021
Project Q3300940 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Profit: Research Therapy methods for the application of therapeutic vaccines HPV-AmpliVak in HPV+ head-neck tumors |
Project Q3300940 in Germany |
Statements
327,791.28 Euro
0 references
409,739.1 Euro
0 references
80.0 percent
0 references
1 October 2020
0 references
30 September 2022
0 references
AmpliVak Immunotherapy GmbH
0 references
52°38'15.29"N, 13°12'20.70"E
0 references
Hennigsdorf, Stadt
0 references
Identifiers
DE_TEMPORARY_3742
0 references